![Clinical Lymphoma Myeloma and Leukemia | Vol 20, Issue 1, Pages A1-A20, e1-e37, 1-56 (January 2020) | ScienceDirect.com by Elsevier Clinical Lymphoma Myeloma and Leukemia | Vol 20, Issue 1, Pages A1-A20, e1-e37, 1-56 (January 2020) | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S2152265019X00154-cov200h.gif)
Clinical Lymphoma Myeloma and Leukemia | Vol 20, Issue 1, Pages A1-A20, e1-e37, 1-56 (January 2020) | ScienceDirect.com by Elsevier
![PDF) Poster: CT-037: The Impact of CD34+ Cell Dose on the Outcome of Allo-HSCT in Adult SAA Patients Conditioned with a Non-ATG-Based Regimen with Post-Transplantation Cyclophosphamide from Fully Matched-Sibling Donors PDF) Poster: CT-037: The Impact of CD34+ Cell Dose on the Outcome of Allo-HSCT in Adult SAA Patients Conditioned with a Non-ATG-Based Regimen with Post-Transplantation Cyclophosphamide from Fully Matched-Sibling Donors](https://i1.rgstatic.net/publication/354234532_Poster_CT-037_The_Impact_of_CD34_Cell_Dose_on_the_Outcome_of_Allo-HSCT_in_Adult_SAA_Patients_Conditioned_with_a_Non-ATG-Based_Regimen_with_Post-Transplantation_Cyclophosphamide_from_Fully_Matched-Sibl/links/6206e129cf7c2349ca0beb52/largepreview.png)
PDF) Poster: CT-037: The Impact of CD34+ Cell Dose on the Outcome of Allo-HSCT in Adult SAA Patients Conditioned with a Non-ATG-Based Regimen with Post-Transplantation Cyclophosphamide from Fully Matched-Sibling Donors
Clinical Lymphoma Myeloma and Leukemia - science journal on Clinical medicine, Health sciences, Biological sciences — download scholarly article PDF and read for free on CyberLeninka open science hub.
![Prognostic and predictive biomarker developments in multiple myeloma | Journal of Hematology & Oncology | Full Text Prognostic and predictive biomarker developments in multiple myeloma | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-021-01162-7/MediaObjects/13045_2021_1162_Figa_HTML.png)
Prognostic and predictive biomarker developments in multiple myeloma | Journal of Hematology & Oncology | Full Text
![PDF) SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia PDF) SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia](https://i1.rgstatic.net/publication/353394473_SOHO_State_of_the_Art_Updates_and_Next_Questions_Management_of_Asparaginase_Toxicity_in_Adolescents_and_Young_Adults_with_Acute_Lymphoblastic_Leukemia/links/60fa4bf00c2bfa282af5c894/largepreview.png)
PDF) SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia
![Clinical Lymphoma Myeloma and Leukemia | Proceedings of the Society of Hematologic Oncology 2019 Annual Meeting | ScienceDirect.com by Elsevier Clinical Lymphoma Myeloma and Leukemia | Proceedings of the Society of Hematologic Oncology 2019 Annual Meeting | ScienceDirect.com by Elsevier](https://ars.els-cdn.com/content/image/1-s2.0-S2152265019X00099-cov200h.gif)
Clinical Lymphoma Myeloma and Leukemia | Proceedings of the Society of Hematologic Oncology 2019 Annual Meeting | ScienceDirect.com by Elsevier
![A Case Report of Chronic Myelogenous Leukemia in a Patient With Multiple Myeloma and a Review of the Literature - Clinical Lymphoma, Myeloma and Leukemia A Case Report of Chronic Myelogenous Leukemia in a Patient With Multiple Myeloma and a Review of the Literature - Clinical Lymphoma, Myeloma and Leukemia](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2005939926/2026493994/gr1.jpg)
A Case Report of Chronic Myelogenous Leukemia in a Patient With Multiple Myeloma and a Review of the Literature - Clinical Lymphoma, Myeloma and Leukemia
![A clinical perspective on plasma cell leukemia; current status and future directions | Blood Cancer Journal A clinical perspective on plasma cell leukemia; current status and future directions | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-021-00414-6/MediaObjects/41408_2021_414_Fig1_HTML.png)
A clinical perspective on plasma cell leukemia; current status and future directions | Blood Cancer Journal
![Frontiers | Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia | Immunology Frontiers | Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia | Immunology](https://www.frontiersin.org/files/Articles/738915/fimmu-12-738915-HTML/image_m/fimmu-12-738915-g001.jpg)
Frontiers | Secondary Immunodeficiency in Hematological Malignancies: Focus on Multiple Myeloma and Chronic Lymphocytic Leukemia | Immunology
![PDF) A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide PDF) A Noninterventional, Observational, European Post-Authorization Safety Study of Patients With Relapsed/Refractory Multiple Myeloma Treated With Lenalidomide](https://i1.rgstatic.net/publication/341354434_A_Noninterventional_Observational_European_Post-Authorization_Safety_Study_of_Patients_With_RelapsedRefractory_Multiple_Myeloma_Treated_With_Lenalidomide/links/5edaa5bd299bf1c67d443d9f/largepreview.png)